While a recent FDA draft guidance raised hopes that cut-price versions of GlaxoSmithKline's blockbuster asthma/COPD product Advair (fluticasone/salmeterol) may arrive earlier than anticipated in the US, the Indian company, Glenmark, has received what's…
written on 03.01.2014